Pharma Regulations in Germany & How Vigilare Supports Seamless Compliance
Germany is Europe’s largest pharma market with strict regulations. Learn how Vigilare helps companies navigate BfArM, EMA, and EU compliance with speed and clarity.
Read More
Germany is Europe’s largest pharma market with strict regulations. Learn how Vigilare helps companies navigate BfArM, EMA, and EU compliance with speed and clarity.
Read More🌐 Introduction The clinical research landscape is evolving rapidly. Traditional site-based trials, while foundational, often face limitations in patient recruitment, retention, and geographic reach. Decentralised Clinical Trials (DCTs) are emerging as a transformative model —
Read More
From Vigilare Biopharma: The recent PRAC meeting (2-5 June 2025) underscores the relentless pace of pharmacovigilance evolution. From gene therapy safety to AI integration and refined risk management for established classes, the demands on sponsors
Read More
TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Australia’s Therapeutic Goods Administration (TGA) is revising its clinical trial and pharmacovigilance guidelines to align with global benchmarks—a move poised to reshape research and drug safety practices.
Read More